414 related articles for article (PubMed ID: 34591954)
41. Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.
Lee C; Banerjee T; Gillespie J; Ceravolo A; Parvinsmith MR; Starita LM; Fields S; Toland AE; Parvin JD
Hum Mutat; 2015 Dec; 36(12):1205-14. PubMed ID: 26350354
[TBL] [Abstract][Full Text] [Related]
42. A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites.
Polanowska J; Martin JS; Garcia-Muse T; Petalcorin MI; Boulton SJ
EMBO J; 2006 May; 25(10):2178-88. PubMed ID: 16628214
[TBL] [Abstract][Full Text] [Related]
43. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.
Atipairin A; Canyuk B; Ratanaphan A
Breast Cancer Res Treat; 2011 Feb; 126(1):203-9. PubMed ID: 20878461
[TBL] [Abstract][Full Text] [Related]
44. BRCA1 is a histone-H2A-specific ubiquitin ligase.
Kalb R; Mallery DL; Larkin C; Huang JT; Hiom K
Cell Rep; 2014 Aug; 8(4):999-1005. PubMed ID: 25131202
[TBL] [Abstract][Full Text] [Related]
45. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability.
Liu F; Han Q; Zhang T; Chang F; Deng J; Huang X; Wang W; Xu Y; Li Q; Xu L; Zhang B; Li W; Li L; Su Y; Li Y; Shao G
Int J Biol Sci; 2022; 18(4):1434-1450. PubMed ID: 35280675
[TBL] [Abstract][Full Text] [Related]
46. BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis.
Salas-Lloret D; García-Rodríguez N; Soto-Hidalgo E; González-Vinceiro L; Espejo-Serrano C; Giebel L; Mateos-Martín ML; de Ru AH; van Veelen PA; Huertas P; Vertegaal ACO; González-Prieto R
Nat Commun; 2024 May; 15(1):4292. PubMed ID: 38769345
[TBL] [Abstract][Full Text] [Related]
47. BRCA1-BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes.
Burdett H; Foglizzo M; Musgrove LJ; Kumar D; Clifford G; Campbell LJ; Heath GR; Zeqiraj E; Wilson MD
Nucleic Acids Res; 2023 Nov; 51(20):11080-11103. PubMed ID: 37823591
[TBL] [Abstract][Full Text] [Related]
48. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
[TBL] [Abstract][Full Text] [Related]
49. Quantitative proteomic identification of the BRCA1 ubiquitination substrates.
Song M; Hakala K; Weintraub ST; Shiio Y
J Proteome Res; 2011 Nov; 10(11):5191-8. PubMed ID: 21950761
[TBL] [Abstract][Full Text] [Related]
50. BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1.
Witus SR; Burrell AL; Farrell DP; Kang J; Wang M; Hansen JM; Pravat A; Tuttle LM; Stewart MD; Brzovic PS; Chatterjee C; Zhao W; DiMaio F; Kollman JM; Klevit RE
Nat Struct Mol Biol; 2021 Mar; 28(3):268-277. PubMed ID: 33589814
[TBL] [Abstract][Full Text] [Related]
51. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
Baer R; Ludwig T
Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
[TBL] [Abstract][Full Text] [Related]
52. BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination.
Becker JR; Clifford G; Bonnet C; Groth A; Wilson MD; Chapman JR
Nature; 2021 Aug; 596(7872):433-437. PubMed ID: 34321663
[TBL] [Abstract][Full Text] [Related]
53. Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.
Morris JR; Pangon L; Boutell C; Katagiri T; Keep NH; Solomon E
Hum Mol Genet; 2006 Feb; 15(4):599-606. PubMed ID: 16403807
[TBL] [Abstract][Full Text] [Related]
54. RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage.
Krais JJ; Wang Y; Patel P; Basu J; Bernhardy AJ; Johnson N
Nat Commun; 2021 Aug; 12(1):5016. PubMed ID: 34408138
[TBL] [Abstract][Full Text] [Related]
55. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
56. Oncogenic BARD1 isoforms expressed in gynecological cancers.
Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
[TBL] [Abstract][Full Text] [Related]
57. Histone tail electrostatics modulate E2-E3 enzyme dynamics: a gateway to regulate ubiquitination machinery.
Ranathunga DTS; Torabifard H
Phys Chem Chem Phys; 2023 Jan; 25(4):3361-3374. PubMed ID: 36633205
[TBL] [Abstract][Full Text] [Related]
58. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
Wu-Baer F; Ludwig T; Baer R
Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
[TBL] [Abstract][Full Text] [Related]
59. BRCA1 DNA-binding activity is stimulated by BARD1.
Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
[TBL] [Abstract][Full Text] [Related]
60. CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1.
Deng J; Zhang T; Liu F; Han Q; Li Q; Guo X; Ma Y; Li L; Shao G
Biochem Biophys Res Commun; 2022 Jun; 611():107-113. PubMed ID: 35487060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
